Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates

Vaccine

Volumn 19, Issue 4-5, 2000, Pages 530-537

  Kim, Soo Kie ^a   Ragupathi, Govindaswami ^a   Cappello, Sarah ^a   Kagan, Ella ^a   Livingston, Philip O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adjuvant; Cancer vaccine; Conjugate vaccine; GD3; GPI 0100; MUC1; QS 21

Indexed keywords

AUTOANTIGEN; CANCER VACCINE; GANGLIOSIDE GD3; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; QS 21; SAPONIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ANTIBODY FORMATION; CA-15-3 ANTIGEN; CANCER VACCINES; CYTOKINES; FEMALE; GANGLIOSIDES; HEMOCYANIN; HYPERSENSITIVITY, DELAYED; IN VITRO; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; VACCINATION; VACCINES, CONJUGATE;

EID: 0011017020     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00195-X     Document Type: Article

References (23)

1. Livingston P.O., Zhang S., Lloyd K.O. Carbohydrate vaccines that induce antibodies against cancer. Part I: Rational. Cancer Immunol. Immunother. 45:1997;1-9.
2. Zhang H., Zhang S., Cheung N.K., Ragupathi G., Livingston P.O. Antibodies can eradicate cancer micrometastases. Cancer Res. 58:1998;2844-2849.
3. Livingston P.O., Wong G.Y.C., Adluri S., Tao Y., Padavan M., Parente R., Hanlon C., Helling F., Ritter G., Oettgen H.F., Old L.J. Improved survival in AJCC stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J. Clin. Oncol. 12:1994;1036-1044.
4. Jones P.C., Sze L.L., Liu P.Y., Morton D.L., Irie R.F. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J. Natl. Cancer Inst. 66:1981;249-254.
5. Riethmuller G., Schneider-Gadicke E., Schlimok G., Schmiegel W., Raab R., Hoffken K., Gruber R., Pichlmaier H., Hirche H., Pichlmayr R., Buggisch P., Witte J. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet. 343:1994;1177-1183.
6. Helling F., Shang Y., Calves M., Oettgen H.F., Livingston P.O. Increased immunogenicity of GD3 conjugate vaccines: comparison of various carrier proteins and selection of GD3-KLH for further testing. Cancer Res. 54:1994;197-203.
7. Helling F., Zhang A., Shang A., Adluri S., Calves M., Koganty R., Longenecker B.M., Oettgen H.F., Livingston P.O. GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res. 55:1995;2783-2788.
8. Livingston P.O. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines. Immunol. Rev. 145:1995;145-166.
9. Kim S.K., Ragupathi G., Musselli C., Choi S.J., Park Y.S., Livingston P.O. Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate vaccines. Vaccine. 18:2000;597-603.
10. Cappello S., Lie N.X., Musselli C., Brezicka F., Livingston P.O., Ragupathi G. Immunization of mice fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells. Cancer Immunol. Immunother. 48:1999;483-492.
11. Zar H.J. Rank correlation. Biostatistical analysis. 1974;243-246 Prentice-Hall, Englewood Cliffs, NJ.
12. Livingston P.O., Zhang S., Lloyd K.O. Carbohydrate vaccines that induce antibodies against cancer. Part I: Rational. Cancer Immunol. Immunother. 45:1997;1-9.
13. Livingston P.O., Koganty R., Longenecker B.M., Lloyd K.O., Calves M. Studies on the immunogenicity of synthetic and natural Thomsen-Friedenreich (TF) antigens in mice: augmentation of the response by Quil A and SAF-m adjuvants and analysis of the specificity of the responses. Vaccine Res. 1:1992;99-109.
14. Zhang S., Walberg L.A., Helling F., Ragupathi G., Adluri S., Lloyd K.O., Livingston P.O. Augmenting the immunogenicity of synthetic MUC-1 vaccines in mice. Cancer Res. 55:1996;3364-3368.
15. Livingston P.O., Adluri S., Zhang S., Chapman P.B., Raychaudhuri S., Merritt J.A. Impact of immunological adjuvants and administration route on HAMA response after immunization with murine monoclonal antibody MELIMMUNE-1 in melanoma patients. Vaccine Res. 4:1995;87-94.
16. Todd C.W., Pozzi L.A., Guarnaccia J.R., Balusubramnian M., Henk W.G., Younger L.E., Newman M.J. Development of an adjuvant-active nonionic block copolymer for use in oil-subunit vaccine formulations. Vaccine. 15:1997;564-570.
17. Weiner G.J., Liu H., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. PNAS. 94:1997;10,833-10,837.
18. Jager E., Ringhoffer M., Dienes H.P., Arand M., Karbach J., Jager D., Ilsemann C., Hagedorn M., Oesch F., Knuth A. Granulocyte-macrophage-colony stimulating factor enhances immune responses to melanoma associated peptides in vivo. Int. J. Cancer. 67:1996;54-62.
19. Ribi E., Amano K., Cantrell J., Schwartzman S., Parker R., Takayama K. Preparation and antitumor activity of nontoxic lipid A. Cancer Immunol. Immunother. 12:1982;91-96.
20. Marciani D, Press JB, Reynolds RC, Pathak AK, Pathak V, Gundy LE, Farmer JT, Koratich MS, May RD. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity. Vaccine 2000;18:3141-51.
21. Lo K.M., Sudo Y., Chen J., Li Y., Kong S.M., Chen L., An Q., Gillies S.D. High level expression and secretion of Fc-X fusion proteins in mammalian cells. Protein Eng. 11:1998;495-500.
22. Kensil C.R., Patel U., Lennick M., Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immunol. 12:1982;91-96.
23. Bennett B., Check I.J., Olsen M.R., Hunter R.L. A comparison of commercially available adjuvants for use in research. J. Immunol. Methods. 153:1992;31.